WRBY

Warby Parker Inc. · NYSE · Healthcare · USD · 10-K for 2025, filed 2026-02-26

Figures on this page computed 2026-11-08 13:18 UTC

Last close

21.29USD

Market data, 2026-11-04

WRBY: weekly closes from 28.73 on 2026-05-15 to 21.29 on 2026-11-04, a move of -25.9%. Prices in USD.

Weekly closes, 2026-05-15 to 2026-11-04

Over that span: -25.9%

Except where said otherwise: 10-K for 2025, filed 2026-02-26

2548.0xP/E
Price / Earnings per Share (diluted)
Source
computed
Fiscal year
2025
Accession
0001504776-26-000006
Reported in
USD
- computed
- 10-K for 2025, filed 2026-02-26
The filing itself
-0.9%ROIC
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
Source
computed
Fiscal year
2025
Accession
0001504776-26-000006
Reported in
USD
- 10-K for 2025, filed 2026-02-26
- 10-K for 2025, filed 2026-02-26
- 10-K for 2025, filed 2026-02-26
- 10-Q for 2025, filed 2026-08-06
- 10-K for 2025, filed 2026-02-26
- 10-Q for 2025, filed 2026-08-06
The filing itself
0.2%Net margin
Net Income / Revenue x 100
Source
computed
Fiscal year
2025
Accession
0001504776-26-000006
Reported in
USD
- 10-K for 2025, filed 2026-02-26
- 10-K for 2025, filed 2026-02-26
The filing itself
5.0%FCF margin
Free Cash Flow / Revenue x 100
Source
computed
Fiscal year
2025
Accession
0001504776-26-000006
Reported in
USD
- 10-K for 2025, filed 2026-02-26
- 10-K for 2025, filed 2026-02-26
The filing itself
0.63Debt/equity
Total Debt / Shareholders' Equity
Source
computed
Fiscal year
2025
Accession
0001504776-26-000006
Reported in
USD
- 10-K for 2025, filed 2026-02-26
- 10-Q for 2025, filed 2026-08-06
The filing itself
n/aDividend yield
We do not hold this figure for this company, so there is nothing to place.
Source
computed
Taken on
2026-11-07
Reported in
USD
- computed

Price is the furthest below its sector's middle: 0.11 against 0.36 on the market's range.

What it pays out: n/aWe do not hold this figure for this company, so there is nothing to place.

Five bars, one line

lens 7 of 9

1.45x

-0.03x

-7.10x

1.16x

1.03x

SalesProfitFree cash flowDebtPrice

Each bar against this company's own average; the line is that average.

Filed2025

Market data2026-11-04

Each against its own average

5 of 5 read

Except where said otherwise: 10-K for 2025, filed 2026-02-26

Sales1.45x
Its own average over 7 years, 602.3M.
Profit-0.03x
Its own average over 7 years, -56.1M.
Free cash flow-7.10x
Its own average over 7 years, -6.2M.
Debt1.16x
Its own average over 4 years, 201.6M.
Price1.03x
Its own average over 6 years, 21. Market data, 2026-11-04

Free cash flow is furthest from its own average, at -7.10 times.

The filed years, as a table

Each line is 100 at 2019-12-31, the first year we hold.

Filed year	Sales	Shares in issue
2019-12-31	100.0	100.0
2020-12-31	106.3	101.2
2021-12-31	146.0	135.9
2022-12-31	161.4	219.3
2023-12-31	180.8	223.9
2024-12-31	208.2	229.6
2025-12-31	235.4	238.6

How sales was got

Source: filed
Statement: income
Fiscal year: 2025
Accession: 0001504776-26-000006
Reported in: USD

The filing itself

How shares in issue was got

Source: filed
Statement: income
Fiscal year: 2025
Accession: 0001504776-26-000006
Reported in: USD

The filing itself

Figures behind the shape

Growth

17.2%

faster is higher, placed against 4,950 companies as of 2026-11-07

Five-year revenue growth rate17.2%
Source
computed
Taken on
2026-11-07
Reported in
USD
- computed
Five-year EPS growth raten/a
We do not hold this figure for this company, so there is nothing to place.
Source
computed
Taken on
2026-11-07
Reported in
USD
- computed
One-year change in net income108.0%
Source
computed
Taken on
2026-11-07
Reported in
USD
- computed

Returns on capital

-0.9%

higher is higher, placed against 5,089 companies as of 2026-11-07

Return on invested capital-0.9%
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
Source
computed
Fiscal year
2025
Accession
0001504776-26-000006
Reported in
USD
- 10-K for 2025, filed 2026-02-26
- 10-K for 2025, filed 2026-02-26
- 10-K for 2025, filed 2026-02-26
- 10-Q for 2025, filed 2026-08-06
- 10-K for 2025, filed 2026-02-26
- 10-Q for 2025, filed 2026-08-06
The filing itself
Return on equity0.5%
Net Income / Shareholders' Equity x 100
Source
computed
Fiscal year
2025
Accession
0001504776-26-000006
Reported in
USD
- 10-K for 2025, filed 2026-02-26
- 10-Q for 2025, filed 2026-08-06
The filing itself
Return on assets0.2%
Net Income / Total Assets x 100
Source
computed
Fiscal year
2025
Accession
0001504776-26-000006
Reported in
USD
- 10-K for 2025, filed 2026-02-26
- 10-Q for 2025, filed 2026-08-06
The filing itself

Margins

54.0%

wider is higher, placed against 3,412 companies as of 2026-11-07

Gross margin54.0%
Gross Profit / Revenue x 100
Source
computed
Fiscal year
2025
Accession
0001504776-26-000006
Reported in
USD
- 10-K for 2025, filed 2026-02-26
- 10-K for 2025, filed 2026-02-26
The filing itself
Operating margin-0.6%
Operating Income / Revenue x 100
Source
computed
Fiscal year
2025
Accession
0001504776-26-000006
Reported in
USD
- 10-K for 2025, filed 2026-02-26
- 10-K for 2025, filed 2026-02-26
The filing itself
Net margin0.2%
Net Income / Revenue x 100
Source
computed
Fiscal year
2025
Accession
0001504776-26-000006
Reported in
USD
- 10-K for 2025, filed 2026-02-26
- 10-K for 2025, filed 2026-02-26
The filing itself
Free cash flow margin5.0%
Free Cash Flow / Revenue x 100
Source
computed
Fiscal year
2025
Accession
0001504776-26-000006
Reported in
USD
- 10-K for 2025, filed 2026-02-26
- 10-K for 2025, filed 2026-02-26
The filing itself

Price

2548.0x

cheaper is higher, placed against 4,362 companies as of 2026-11-07

Price to earnings2548.0x
Price / Earnings per Share (diluted)
Source
computed
Fiscal year
2025
Accession
0001504776-26-000006
Reported in
USD
- computed
- 10-K for 2025, filed 2026-02-26
The filing itself
Price to book8.7x10-Q for 2025, filed 2026-08-06
Price / Book Value per Share, where BVPS = Shareholders' Equity / Diluted Shares
Source
computed
Fiscal year
2025
Accession
0001504776-26-000019
Reported in
USD
- computed
- 10-Q for 2025, filed 2026-08-06
- computed
- 10-K for 2025, filed 2026-02-26
The filing itself
EV to EBITDA69.7x
Enterprise Value / EBITDA, where EV = Market Cap + Total Debt - Cash
Source
computed
Fiscal year
2025
Accession
0001504776-26-000006
Reported in
USD
- computed
- 10-K for 2025, filed 2026-02-26
- 10-K for 2025, filed 2026-02-26
- 10-Q for 2025, filed 2026-08-06
- 10-K for 2025, filed 2026-02-26
The filing itself
Price to sales ratio3.7x
Market Cap / Revenue, where Market Cap = Price x Diluted Shares
Source
computed
Fiscal year
2025
Accession
0001504776-26-000006
Reported in
USD
- computed
- 10-K for 2025, filed 2026-02-26
- 10-K for 2025, filed 2026-02-26
The filing itself

Safety

0.63

safer is higher, placed against 3,227 companies as of 2026-11-07

Debt to equity0.63
Total Debt / Shareholders' Equity
Source
computed
Fiscal year
2025
Accession
0001504776-26-000006
Reported in
USD
- 10-K for 2025, filed 2026-02-26
- 10-Q for 2025, filed 2026-08-06
The filing itself
Current ratio2.3510-Q for 2025, filed 2026-08-06
Current Assets / Current Liabilities
Source
computed
Fiscal year
2025
Accession
0001504776-26-000019
Reported in
USD
- 10-Q for 2025, filed 2026-08-06
- 10-Q for 2025, filed 2026-08-06
The filing itself
Interest coveragen/a
We do not hold this figure for this company, so there is nothing to place.
Operating Income / Interest Expense
Source
computed
Fiscal year
2025
Accession
0001504776-26-000006
Reported in
USD
- 10-K for 2025, filed 2026-02-26
- 10-K for 2025, filed 2026-02-26
The filing itself
Altman Z-Score5.61
1.2 x A + 1.4 x B + 3.3 x C + 0.6 x D + 1.0 x E (A=WC/TA, B=RE/TA, C=EBIT/TA, D=MktCap/TL, E=Rev/TA)
Source
computed
Taken on
2026-11-07
Reported in
USD
- Computed from the 10-K for 2025, filed 2026-02-26
- Computed from the 10-K for 2025, filed 2026-02-26
- Computed from the 10-K for 2025, filed 2026-02-26
- Computed from the 10-K for 2025, filed 2026-02-26
- Computed from the 10-K for 2025, filed 2026-02-26

What it pays out

n/a

We do not hold this figure for this company, so there is nothing to place.

more, and better covered, is higher, with no cohort held

Dividend yieldn/a
We do not hold this figure for this company, so there is nothing to place.
Source
computed
Taken on
2026-11-07
Reported in
USD
- computed
Payout ration/a
We do not hold this figure for this company, so there is nothing to place.
Common Dividends Paid / Net Income x 100, both from the latest filed fiscal year
Source
computed
Fiscal year
2025
Accession
0001504776-26-000006
Reported in
USD
- 10-K for 2025, filed 2026-02-26
- Computed from the 10-K for 2025, filed 2026-02-26
- 10-K for 2025, filed 2026-02-26
The filing itself
Dividend cover ration/a
We do not hold this figure for this company, so there is nothing to place.
Source
computed
Taken on
2026-11-07
Reported in
USD
- computed

Share a finding

A link to the finding, not to you: it carries nothing about your account.